Sökning: onr:"swepub:oai:DiVA.org:umu-22455" > Expression of eryth...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03005naa a2200373 4500 | |
001 | oai:DiVA.org:umu-22455 | |
003 | SwePub | |
008 | 090511s2009 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-224552 URI |
024 | 7 | a https://doi.org/10.1159/0002168442 DOI |
040 | a (SwePub)umu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Papworth, Karin,d 1964-u Umeå universitet,Onkologi4 aut0 (Swepub:umu)kanpah98 |
245 | 1 0 | a Expression of erythropoietin and its receptor in human renal cell carcinoma |
264 | 1 | b Springer Science and Business Media LLC,c 2009 |
338 | a print2 rdacarrier | |
520 | a Objective: To investigate the prognostic impact of erythropoietin (EPO) and EPO-receptor (EPO-R) expression in tumour as well as serum EPO in patients with renal cell carcinoma (RCC). Methods: Using immunohistochemistry, EPO and EPO-R were assessed in tissue microarrays from 195 RCCs. RCC type, TNM stage, nuclear grade, survival, EPO and haemoglobin (Hb) levels in blood were registered. Results: Strong expression of EPO and EPO-R in tumour tissue was found in 83 and 56%, respectively. EPO and EPO-R expression differed between RCC types. Serum EPO and blood Hb did not correlate to the expression of EPO or EPO-R. A positive correlation was found between the expression of EPO and EPO-R (p = 0.028). Survival was not related to tumour EPO, whereas strong EPO-R expression indicated a non-significantly worse prognosis. Serum EPO correlated positively to TNM stage and nuclear grade and negatively to survival. A multivariate analysis showed that TNM stage and nuclear grade were independent prognostic factors. Tumour EPO and EPO-R expression as well as serum EPO added no independent prognostic information. Conclusion: No correlation between EPO or EPO-R in tumour tissue and serum EPO or blood Hb was found. Neither EPO, EPO-R in tumour tissue nor serum EPO are independent prognostic factors. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a Oncology | |
653 | a Onkologi | |
653 | a Oncology | |
653 | a onkologi | |
700 | 1 | a Bergh, Andersu Umeå universitet,Patologi4 aut0 (Swepub:umu)anbe0010 |
700 | 1 | a Grankvist, Kjellu Umeå universitet,Klinisk kemi4 aut0 (Swepub:umu)kjgr0002 |
700 | 1 | a Ljungberg, Börjeu Umeå universitet,Urologi och andrologi4 aut0 (Swepub:umu)bolj0001 |
700 | 1 | a Rasmuson, Torgnyu Umeå universitet,Onkologi4 aut0 (Swepub:umu)tora0001 |
710 | 2 | a Umeå universitetb Onkologi4 org |
773 | 0 | t Tumor Biologyd : Springer Science and Business Media LLCg 30:2, s. 86-92q 30:2<86-92x 1010-4283x 1423-0380 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-22455 |
856 | 4 8 | u https://doi.org/10.1159/000216844 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.